Pretreatment neutrophil-lymphocyte ratio predicts the long-term survival of patients with sinonasal malignancy

Int Forum Allergy Rhinol. 2022 Dec;12(12):1554-1557. doi: 10.1002/alr.23022. Epub 2022 May 30.

Authors

Kyung Won Kwon^{1

2}, Jeong Heon Kim¹, Dong Kyu Lee¹, Yoo-Sam Chung¹, Yong Ju Jang¹, Ji Heui Kim¹, Myeong Sang Yu¹

Affiliations

¹ Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
² Department of Otolaryngology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea.

PMID: 35594205
DOI: 10.1002/alr.23022

No abstract available

Keywords: biomarker; paranasal sinus diseases; statistics.

MeSH terms

Humans
Lymphocytes
Neutrophils*
Paranasal Sinus Neoplasms* / pathology
Prognosis
Retrospective Studies